PuSH - Publikationsserver des Helmholtz Zentrums München

Günthner, R.* ; Knipping, L.* ; Jeruschke, S.* ; Satanoskij, R.* ; Lorenz-Depiereux, B. ; Hemmer, C.* ; Braunisch, M.C.* ; Riedhammer, K.M.* ; Ćomić, J.* ; Tönshoff, B.* ; Tasic, V.* ; Abazi-Emini, N.* ; Nushi-Stavileci, V.* ; Buiting, K.* ; Gjorgjievski, N.* ; Momirovska, A.* ; Patzer, L.* ; Kirschstein, M.* ; Gross, O.* ; Lungu, A.* ; Weber, S.* ; Renders, L.* ; Heemann, U.* ; Meitinger, T.* ; Büscher, A.K.* ; Hoefele, J.*

Renal X-inactivation in female individuals with X-linked Alport syndrome primarily determined by age.

Front. Med. 9:953643 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
X-linked Alport syndrome (AS) caused by hemizygous disease-causing variants in COL4A5 primarily affects males. Females with a heterozygous state show a diverse phenotypic spectrum ranging from microscopic hematuria to end-stage kidney disease (ESKD) and extrarenal manifestations. In other X-linked diseases, skewed X-inactivation leads to preferential silencing of one X-chromosome and thus can determine the phenotype in females. We aimed to show a correlation between X-inactivation in blood and urine-derived renal cells and clinical phenotype of females with a heterozygous disease-causing variant in COL4A5 compared to healthy controls. A total of 56 females with a heterozygous disease-causing COL4A5 variant and a mean age of 31.6 ± 18.3 SD years were included in this study. A total of 94% had hematuria, 62% proteinuria >200 mg/day, yet only 7% had decreased eGFR. Using human androgen receptor assay X-inactivation was examined in blood cells of all 56 individuals, in urine-derived cells of 27 of these individuals and in all healthy controls. X-inactivation did not correlate with age of first manifestation, proteinuria or eGFR neither in blood, nor in urine. The degree of X-inactivation showed a moderate association with age, especially in urine-derived cells of the patient cohort (rho = 0.403, p = 0.037). Determination of X-inactivation allelity revealed a shift of X-inactivation toward the COL4A5 variant bearing allele. This is the first study examining X-inactivation of urine-derived cells from female individuals with AS. A correlation between phenotype and X-inactivation could not be observed suspecting other genetic modifiers shaping the phenotype in female individuals with AS. The association of X-inactivation with age in urine-derived cells suggests an escape-mechanism inactivating the COL4A5 variant carrying allele in female individuals with AS.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Alport Syndrome ; Col4a5 ; X-inactivation ; End-stage Kidney Disease ; Microscopic Hematuria ; Proteinuria ; Urine-derived Cells
ISSN (print) / ISBN 2296-858X
e-ISSN 2296-858X
Zeitschrift Frontiers in Medicine
Quellenangaben Band: 9, Heft: , Seiten: , Artikelnummer: 953643 Supplement: ,
Verlag Frontiers
Verlagsort Lausanne
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology II (EPI2)
Förderungen Technical University of Munich (TUM)
German Pediatric Nephrology Association